期刊文献+

下咽癌相关血浆肿瘤标志物的蛋白质组学筛选

Screening of plasma tumor biomarkers for hypopharyngeal carcinoma by proteomics method
下载PDF
导出
摘要 目的分析下咽癌患者与健康人血浆中差异表达的蛋白质组,筛选潜在的与下咽癌诊断密切相关的血浆肿瘤标志物。方法取下咽癌患者与健康人空腹血浆标本各6例分别等量混合成2组样本,去除血浆高丰度蛋白后,利用双向电泳(2-DE)进行分离,经软件分析后找出表达量变化2倍以上的差异蛋白点,接着利用基质辅助激光解吸电离飞行时间质谱(MALDI-TOF/TOF)进行差异蛋白质鉴定,然后利用Western blotting对α2-HS-糖蛋白的表达量进行验证。结果下咽癌患者与健康人血浆相比较,筛选出表达量差异2倍以上的差异蛋白点共11个,其中表达上调的有5个,表达下调的有6个,进行质谱分析后,表达上调的蛋白有α2-HS-糖蛋白、结合珠蛋白;表达下调的蛋白有免疫球蛋白κ链C结构域、载脂蛋白A1。Western blotting结果表明,α-2-HS-糖蛋白的表达上调,与双向电泳结果一致。结论下咽癌患者与健康人血浆的蛋白质表达谱表现出一定差异,这些差异蛋白有可能成为下咽癌患者早期诊断的特异性血浆肿瘤标志物。 Objective To screen tumor biomarkers in the plasma close related with hypopharyngeal carcinoma.Methods Pooled plasm from 6 patients with hypopharyngeal carcinoma and 6 healthy individuals were collected.After removal of highabundance plasm proteins,two-dimensional gel electrophoresis(2-DE) was performed to isolate the total proteins,and the protein spots with more than 2-fold differential expressions were detected by 2D analysis software followed by identification by MALDI-TOF/TOF mass spectrometer.Western blotting was performed to validate the expression level of α2-HSglycoprotein.Results A total of 11 differentially expressed protein spots were selected,including 5 upregulated proteins and 6 downregulated proteins.MALDI-TOF/TOF identified the upregulated proteins in hypopharyngeal carcinoma patients as alpha-2-HS-glycoprotein and haptoglobin and downregulated ones as Ig kappa chain C region and apolipoprotein A-I.Western blotting demonstrated that α-2-HS-glycoprotein expression level was consistent with that detected by 2-DE.Conclusion Patients with hypopharyngeal carcinoma show different plasma protein profiles from healthy individuals.These differentially expressed proteins may serve as potential specific tumor biomarkers for hypopharyngeal carcinoma.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2013年第8期1173-1176,共4页 Journal of Southern Medical University
基金 国家自然科学基金(81172053) 教育部高等学校博士学科点专项科研基金(20104433120017) 广东省自然科学基金(10151051501000068)~~
关键词 下咽癌 头颈部肿瘤 肿瘤标志物 蛋白质组学 血浆 hypopharyngeal carcinoma head and neck neoplasm tumor biomarkers proteomics plasm
  • 相关文献

参考文献15

  • 1Keereweer S,Kerrebijn JD,A1-Mamgani A,et al.Chemoradiation for advanced hypopharyngeal carcinoma:a retrospective study on efficacy,morbidity and quality of life[J].Eur Arch Otorhinolaryngol,2012,269(3):939-46.
  • 2Nishimura H,Sasaki R,Yoshida K,et al.Radiotherapy for stage Ⅰ or Ⅱ hypopharyngeal carcinoma[J].J Radiat Res (Tokyo),2012,53(6):892-9.
  • 3Chedid HM,Franzi SA,Rapoport A,et al.Impact of combination therapy on disease free survival in hypopharynx cancer[J].Rev Col Bras Cir,2010,37(6):385-9.
  • 4Eckel HE,Staar S,Volling P,et al.Surgical treatment for hypopharynx carcinoma:feasibility,mortality,and results[J].Otolaryngol Head Neck Surg,2001,124(5):561-9.
  • 5Oh JM,Brichory F,Puravs E,et al.A database of protein expression in lung cancer[J].Proteomics,2001,1(10):1303-19.
  • 6Chen G,Gharib TG,Huang CC,et al.Proteomic analysis of lung adenocarcinoma:identification of a highly expressed set of proteins in tumors[J].Clin Cancer Res,2002,8(7):2298-305.
  • 7田文栋,曾宗渊,于文斌,李湘平.下咽鳞癌患者血清比较蛋白质组学研究[J].中华实验外科杂志,2010,27(6):829-831. 被引量:6
  • 8田文栋,曾宗渊,于文斌,李湘平.应用SELDI技术建立下咽鳞癌放疗疗效预测模型[J].南方医科大学学报,2010,30(6):1282-1287. 被引量:2
  • 9Byori R.Proteomics for biomarker development toward personalized medicine[J].Rinsho Byori,2012,60(7):644-9.
  • 10Mori K,Emoto M,Fetuin-A IM.A multifunctional protein[J].Recent Pat Endocr Metab Immune Drug Discov,2011,5(2):124-46.

二级参考文献19

  • 1李炜,刘炳亚,李建芳,陈雪华,李琦,蔡劬,顾琴龙,朱正纲,林言箴.蛋白质组技术在胃癌相关标志物筛查中的应用[J].中华实验外科杂志,2006,23(10):1210-1212. 被引量:14
  • 2Gourin CG,Terris DJ.Carcinoma of the hypopharynx.Surg Oncol Clin N Am,2004,13:81-98.
  • 3Lee KJ.Essential otolaryngology:head and neck surgery,Ninth Edition.New York:Mcgraw-hill Professional Publishing,2008:676-707.
  • 4Gourin CG,Xia ZS,Han Y,et al.Serum protein profile analysis in patients with head and neck squamous cell carcinoma.Arch Otolaryngol Head Neck Surg,2006,132:390-397.
  • 5Gourin CG,Moretz WH,Weinberger PM,et al.Serum protein profile analysis following definitive treatment in patients with head and neck squamous cell carcinoma.Arch Otohryngol Head Neck Surg,2007,133:1125-1130.
  • 6Zhou L,Cheng L,Tao L,et al.Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.Acta Otolaryngol,2006,126:853-860.
  • 7唐平章,吴雪溪.下咽癌外科[M]/屠规益.现代头颈肿瘤外科学.北京:科学出版社,2004:593-612.
  • 8Gourin CG, Ten-is DJ. Carcinoma of the hypopharynx [J]. Surg Oncol Clin N Am, 2004, 13(1): 81-98.
  • 9Lee KJ. Essential otolaryngology: Head and neck surgery [M] //Ninth edition. New York: Mcgraw-hill Professional Publishing, 2008: 676-707.
  • 10Sasaki CT, Jassin B. Cancer of the pharynx and larynx[J]. Am J Med, 2001, 111 (Suppl 8A): 118S-123S.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部